Table of Content

1 Gene Therapies for Tumor Treatment Market Overview
1.1 Gene Therapies for Tumor Treatment Product Scope
1.2 Gene Therapies for Tumor Treatment Segment by Type
1.2.1 Global Gene Therapies for Tumor Treatment Sales by Type (2016 & 2021 & 2027)
1.2.2 Gene Induced Immunotherapy
1.2.3 Oncolytic Virotherapy
1.2.4 Gene Transfer
1.3 Gene Therapies for Tumor Treatment Segment by Application
1.3.1 Global Gene Therapies for Tumor Treatment Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Gene Therapies for Tumor Treatment Market Estimates and Forecasts (2016-2027)
1.4.1 Global Gene Therapies for Tumor Treatment Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Gene Therapies for Tumor Treatment Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Gene Therapies for Tumor Treatment Price Trends (2016-2027)

2 Gene Therapies for Tumor Treatment Estimates and Forecasts by Region
2.1 Global Gene Therapies for Tumor Treatment Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Gene Therapies for Tumor Treatment Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Gene Therapies for Tumor Treatment Sales Market Share by Region (2016-2021)
2.2.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Region (2016-2021)
2.3 Global Gene Therapies for Tumor Treatment Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Gene Therapies for Tumor Treatment Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Gene Therapies for Tumor Treatment Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Gene Therapies for Tumor Treatment Estimates and Projections (2016-2027)
2.4.2 Europe Gene Therapies for Tumor Treatment Estimates and Projections (2016-2027)
2.4.3 China Gene Therapies for Tumor Treatment Estimates and Projections (2016-2027)
2.4.4 Japan Gene Therapies for Tumor Treatment Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Gene Therapies for Tumor Treatment Estimates and Projections (2016-2027)
2.4.6 India Gene Therapies for Tumor Treatment Estimates and Projections (2016-2027)
3 Global Gene Therapies for Tumor Treatment Competition Landscape by Players
3.1 Global Top Gene Therapies for Tumor Treatment Players by Sales (2016-2021)
3.2 Global Top Gene Therapies for Tumor Treatment Players by Revenue (2016-2021)
3.3 Global Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Therapies for Tumor Treatment as of 2020)
3.4 Global Gene Therapies for Tumor Treatment Average Price by Company (2016-2021)
3.5 Manufacturers Gene Therapies for Tumor Treatment Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Gene Therapies for Tumor Treatment Market Size by Type
4.1 Global Gene Therapies for Tumor Treatment Historic Market Review by Type (2016-2021)
4.1.1 Global Gene Therapies for Tumor Treatment Sales Market Share by Type (2016-2021)
4.1.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2016-2021)
4.1.3 Global Gene Therapies for Tumor Treatment Price by Type (2016-2021)
4.2 Global Gene Therapies for Tumor Treatment Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Gene Therapies for Tumor Treatment Sales Forecast by Type (2022-2027)
4.2.2 Global Gene Therapies for Tumor Treatment Revenue Forecast by Type (2022-2027)
4.2.3 Global Gene Therapies for Tumor Treatment Price Forecast by Type (2022-2027)
5 Global Gene Therapies for Tumor Treatment Market Size by Application
5.1 Global Gene Therapies for Tumor Treatment Historic Market Review by Application (2016-2021)
5.1.1 Global Gene Therapies for Tumor Treatment Sales Market Share by Application (2016-2021)
5.1.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2016-2021)
5.1.3 Global Gene Therapies for Tumor Treatment Price by Application (2016-2021)
5.2 Global Gene Therapies for Tumor Treatment Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Gene Therapies for Tumor Treatment Sales Forecast by Application (2022-2027)
5.2.2 Global Gene Therapies for Tumor Treatment Revenue Forecast by Application (2022-2027)
5.2.3 Global Gene Therapies for Tumor Treatment Price Forecast by Application (2022-2027)

6 North America Gene Therapies for Tumor Treatment Market Facts & Figures
6.1 North America Gene Therapies for Tumor Treatment Sales by Company
6.1.1 North America Gene Therapies for Tumor Treatment Sales by Company (2016-2021)
6.1.2 North America Gene Therapies for Tumor Treatment Revenue by Company (2016-2021)
6.2 North America Gene Therapies for Tumor Treatment Sales Breakdown by Type
6.2.1 North America Gene Therapies for Tumor Treatment Sales Breakdown by Type (2016-2021)
6.2.2 North America Gene Therapies for Tumor Treatment Sales Breakdown by Type (2022-2027)
6.3 North America Gene Therapies for Tumor Treatment Sales Breakdown by Application
6.3.1 North America Gene Therapies for Tumor Treatment Sales Breakdown by Application (2016-2021)
6.3.2 North America Gene Therapies for Tumor Treatment Sales Breakdown by Application (2022-2027)

7 Europe Gene Therapies for Tumor Treatment Market Facts & Figures
7.1 Europe Gene Therapies for Tumor Treatment Sales by Company
7.1.1 Europe Gene Therapies for Tumor Treatment Sales by Company (2016-2021)
7.1.2 Europe Gene Therapies for Tumor Treatment Revenue by Company (2016-2021)
7.2 Europe Gene Therapies for Tumor Treatment Sales Breakdown by Type
7.2.1 Europe Gene Therapies for Tumor Treatment Sales Breakdown by Type (2016-2021)
7.2.2 Europe Gene Therapies for Tumor Treatment Sales Breakdown by Type (2022-2027)
7.3 Europe Gene Therapies for Tumor Treatment Sales Breakdown by Application
7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)

8 China Gene Therapies for Tumor Treatment Market Facts & Figures
8.1 China Gene Therapies for Tumor Treatment Sales by Company
8.1.1 China Gene Therapies for Tumor Treatment Sales by Company (2016-2021)
8.1.2 China Gene Therapies for Tumor Treatment Revenue by Company (2016-2021)
8.2 China Gene Therapies for Tumor Treatment Sales Breakdown by Type
8.2.1 China Gene Therapies for Tumor Treatment Sales Breakdown by Type (2016-2021)
8.2.2 China Gene Therapies for Tumor Treatment Sales Breakdown by Type (2022-2027)
8.3 China Gene Therapies for Tumor Treatment Sales Breakdown by Application
8.3.1 China 247 Sales Breakdown by Application (2016-2021)
8.3.2 China 247 Sales Breakdown by Application (2022-2027)

9 Japan Gene Therapies for Tumor Treatment Market Facts & Figures
9.1 Japan Gene Therapies for Tumor Treatment Sales by Company
9.1.1 Japan Gene Therapies for Tumor Treatment Sales by Company (2016-2021)
9.1.2 Japan Gene Therapies for Tumor Treatment Revenue by Company (2016-2021)
9.2 Japan Gene Therapies for Tumor Treatment Sales Breakdown by Type
9.2.1 Japan Gene Therapies for Tumor Treatment Sales Breakdown by Type (2016-2021)
9.2.2 Japan Gene Therapies for Tumor Treatment Sales Breakdown by Type (2022-2027)
9.3 Japan Gene Therapies for Tumor Treatment Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Gene Therapies for Tumor Treatment Market Facts & Figures
10.1 Southeast Asia Gene Therapies for Tumor Treatment Sales by Company
10.1.1 Southeast Asia Gene Therapies for Tumor Treatment Sales by Company (2016-2021)
10.1.2 Southeast Asia Gene Therapies for Tumor Treatment Revenue by Company (2016-2021)
10.2 Southeast Asia Gene Therapies for Tumor Treatment Sales Breakdown by Type
10.2.1 Southeast Asia Gene Therapies for Tumor Treatment Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Gene Therapies for Tumor Treatment Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Gene Therapies for Tumor Treatment Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Gene Therapies for Tumor Treatment Market Facts & Figures
11.1 India Gene Therapies for Tumor Treatment Sales by Company
11.1.1 India Gene Therapies for Tumor Treatment Sales by Company (2016-2021)
11.1.2 India Gene Therapies for Tumor Treatment Revenue by Company (2016-2021)
11.2 India Gene Therapies for Tumor Treatment Sales Breakdown by Type
11.2.1 India Gene Therapies for Tumor Treatment Sales Breakdown by Type (2016-2021)
11.2.2 India Gene Therapies for Tumor Treatment Sales Breakdown by Type (2022-2027)
11.3 India Gene Therapies for Tumor Treatment Sales Breakdown by Application
11.3.1 India Gene Therapies for Tumor Treatment Sales Breakdown by Application (2016-2021)
11.3.2 India Gene Therapies for Tumor Treatment Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Gene Therapies for Tumor Treatment Business
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Gene Therapies for Tumor Treatment Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Gene Therapies for Tumor Treatment Products Offered
12.1.5 Novartis Recent Development
12.2 Kite Pharma
12.2.1 Kite Pharma Corporation Information
12.2.2 Kite Pharma Business Overview
12.2.3 Kite Pharma Gene Therapies for Tumor Treatment Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Kite Pharma Gene Therapies for Tumor Treatment Products Offered
12.2.5 Kite Pharma Recent Development
12.3 Amgen
12.3.1 Amgen Corporation Information
12.3.2 Amgen Business Overview
12.3.3 Amgen Gene Therapies for Tumor Treatment Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Amgen Gene Therapies for Tumor Treatment Products Offered
12.3.5 Amgen Recent Development
12.4 Shanghai Sunway
12.4.1 Shanghai Sunway Corporation Information
12.4.2 Shanghai Sunway Business Overview
12.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Shanghai Sunway Gene Therapies for Tumor Treatment Products Offered
12.4.5 Shanghai Sunway Recent Development
12.5 Sibiono
12.5.1 Sibiono Corporation Information
12.5.2 Sibiono Business Overview
12.5.3 Sibiono Gene Therapies for Tumor Treatment Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sibiono Gene Therapies for Tumor Treatment Products Offered
12.5.5 Sibiono Recent Development
...

13 Gene Therapies for Tumor Treatment Manufacturing Cost Analysis
13.1 Gene Therapies for Tumor Treatment Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Gene Therapies for Tumor Treatment
13.4 Gene Therapies for Tumor Treatment Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Gene Therapies for Tumor Treatment Distributors List
14.3 Gene Therapies for Tumor Treatment Customers

15 Market Dynamics
15.1 Gene Therapies for Tumor Treatment Market Trends
15.2 Gene Therapies for Tumor Treatment Drivers
15.3 Gene Therapies for Tumor Treatment Market Challenges
15.4 Gene Therapies for Tumor Treatment Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Gene Therapies for Tumor Treatment Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Gene Therapies for Tumor Treatment Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Gene Therapies for Tumor Treatment Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Gene Therapies for Tumor Treatment Sales (K Units) by Region (2016-2021)
Table 5. Global Gene Therapies for Tumor Treatment Sales Market Share by Region (2016-2021)
Table 6. Global Gene Therapies for Tumor Treatment Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Gene Therapies for Tumor Treatment Revenue Share by Region (2016-2021)
Table 8. Global Gene Therapies for Tumor Treatment Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Gene Therapies for Tumor Treatment Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Gene Therapies for Tumor Treatment Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Gene Therapies for Tumor Treatment Revenue Share Forecast by Region (2022-2027)
Table 12. Global Gene Therapies for Tumor Treatment Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Gene Therapies for Tumor Treatment Sales Share by Company (2016-2021)
Table 14. Global Gene Therapies for Tumor Treatment Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Gene Therapies for Tumor Treatment Revenue Share by Company (2016-2021)
Table 16. Global Gene Therapies for Tumor Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapies for Tumor Treatment as of 2020)
Table 17. Global Gene Therapies for Tumor Treatment Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Gene Therapies for Tumor Treatment Manufacturing Sites and Area Served
Table 19. Manufacturers Gene Therapies for Tumor Treatment Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Gene Therapies for Tumor Treatment Sales (K Units) by Type (2016-2021)
Table 22. Global Gene Therapies for Tumor Treatment Sales Share by Type (2016-2021)
Table 23. Global Gene Therapies for Tumor Treatment Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Gene Therapies for Tumor Treatment Price (USD/Unit) by Type (2016-2021)
Table 25. Global Gene Therapies for Tumor Treatment Sales Share by Type (2022-2027)
Table 26. Global Gene Therapies for Tumor Treatment Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Gene Therapies for Tumor Treatment Revenue Share by Type (2022-2027)
Table 28. Global Gene Therapies for Tumor Treatment Price (USD/Unit) by Type (2022-2027)
Table 29. Global Gene Therapies for Tumor Treatment Sales (K Units) by Application (2016-2021)
Table 30. Global Gene Therapies for Tumor Treatment Sales Share by Application (2016-2021)
Table 31. Global Gene Therapies for Tumor Treatment Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Gene Therapies for Tumor Treatment Price (USD/Unit) by Application (2016-2021)
Table 33. Global Gene Therapies for Tumor Treatment Sales (K Units) by Application (2022-2027)
Table 34. Global Gene Therapies for Tumor Treatment Sales Share by Application (2022-2027)
Table 35. Global Gene Therapies for Tumor Treatment Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Gene Therapies for Tumor Treatment Revenue Share by Application (2022-2027)
Table 37. Global Gene Therapies for Tumor Treatment Price (USD/Unit) by Application (2022-2027)
Table 38. North America Gene Therapies for Tumor Treatment Sales (K Units) by Company (2016-2021)
Table 39. North America Gene Therapies for Tumor Treatment Sales Market Share by Company (2016-2021)
Table 40. North America Gene Therapies for Tumor Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Gene Therapies for Tumor Treatment Revenue Market Share by Company (2016-2021)
Table 42. North America Gene Therapies for Tumor Treatment Sales by Type (2016-2021) & (K Units)
Table 43. North America Gene Therapies for Tumor Treatment Sales Market Share by Type (2016-2021)
Table 44. North America Gene Therapies for Tumor Treatment Sales by Type (2022-2027) & (K Units)
Table 45. North America Gene Therapies for Tumor Treatment Sales Market Share by Type (2022-2027)
Table 46. North America Gene Therapies for Tumor Treatment Sales by Application (2016-2021) & (K Units)
Table 47. North America Gene Therapies for Tumor Treatment Sales Market Share by Application (2016-2021)
Table 48. North America Gene Therapies for Tumor Treatment Sales by Application (2022-2027) & (K Units)
Table 49. North America Gene Therapies for Tumor Treatment Sales Market Share by Application (2022-2027)
Table 50. Europe Gene Therapies for Tumor Treatment Sales (K Units) by Company (2016-2021)
Table 51. Europe Gene Therapies for Tumor Treatment Sales Market Share by Company (2016-2021)
Table 52. Europe Gene Therapies for Tumor Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Gene Therapies for Tumor Treatment Revenue Market Share by Company (2016-2021)
Table 54. Europe Gene Therapies for Tumor Treatment Sales by Type (2016-2021) & (K Units)
Table 55. Europe Gene Therapies for Tumor Treatment Sales Market Share by Type (2016-2021)
Table 56. Europe Gene Therapies for Tumor Treatment Sales by Type (2022-2027) & (K Units)
Table 57. Europe Gene Therapies for Tumor Treatment Sales Market Share by Type (2022-2027)
Table 58. Europe Gene Therapies for Tumor Treatment Sales by Application (2016-2021) & (K Units)
Table 59. Europe Gene Therapies for Tumor Treatment Sales Market Share by Application (2016-2021)
Table 60. Europe Gene Therapies for Tumor Treatment Sales by Application (2022-2027) & (K Units)
Table 61. Europe Gene Therapies for Tumor Treatment Sales Market Share by Application (2022-2027)
Table 62. China Gene Therapies for Tumor Treatment Sales (K Units) by Company (2016-2021)
Table 63. China Gene Therapies for Tumor Treatment Sales Market Share by Company (2016-2021)
Table 64. China Gene Therapies for Tumor Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Gene Therapies for Tumor Treatment Revenue Market Share by Company (2016-2021)
Table 66. China Gene Therapies for Tumor Treatment Sales by Type (2016-2021) & (K Units)
Table 67. China Gene Therapies for Tumor Treatment Sales Market Share by Type (2016-2021)
Table 68. China Gene Therapies for Tumor Treatment Sales by Type (2022-2027) & (K Units)
Table 69. China Gene Therapies for Tumor Treatment Sales Market Share by Type (2022-2027)
Table 70. China Gene Therapies for Tumor Treatment Sales by Application (2016-2021) & (K Units)
Table 71. China Gene Therapies for Tumor Treatment Sales Market Share by Application (2016-2021)
Table 72. China Gene Therapies for Tumor Treatment Sales by Application (2022-2027) & (K Units)
Table 73. China Gene Therapies for Tumor Treatment Sales Market Share by Application (2022-2027)
Table 74. Japan Gene Therapies for Tumor Treatment Sales (K Units) by Company (2016-2021)
Table 75. Japan Gene Therapies for Tumor Treatment Sales Market Share by Company (2016-2021)
Table 76. Japan Gene Therapies for Tumor Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Gene Therapies for Tumor Treatment Revenue Market Share by Company (2016-2021)
Table 78. Japan Gene Therapies for Tumor Treatment Sales by Type (2016-2021) & (K Units)
Table 79. Japan Gene Therapies for Tumor Treatment Sales Market Share by Type (2016-2021)
Table 80. Japan Gene Therapies for Tumor Treatment Sales by Type (2022-2027) & (K Units)
Table 81. Japan Gene Therapies for Tumor Treatment Sales Market Share by Type (2022-2027)
Table 82. Japan Gene Therapies for Tumor Treatment Sales by Application (2016-2021) & (K Units)
Table 83. Japan Gene Therapies for Tumor Treatment Sales Market Share by Application (2016-2021)
Table 84. Japan Gene Therapies for Tumor Treatment Sales by Application (2022-2027) & (K Units)
Table 85. Japan Gene Therapies for Tumor Treatment Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Gene Therapies for Tumor Treatment Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Gene Therapies for Tumor Treatment Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Gene Therapies for Tumor Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Gene Therapies for Tumor Treatment Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Gene Therapies for Tumor Treatment Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Gene Therapies for Tumor Treatment Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Gene Therapies for Tumor Treatment Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Gene Therapies for Tumor Treatment Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Gene Therapies for Tumor Treatment Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Gene Therapies for Tumor Treatment Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Gene Therapies for Tumor Treatment Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Gene Therapies for Tumor Treatment Sales Market Share by Application (2022-2027)
Table 98. India Gene Therapies for Tumor Treatment Sales (K Units) by Company (2016-2021)
Table 99. India Gene Therapies for Tumor Treatment Sales Market Share by Company (2016-2021)
Table 100. India Gene Therapies for Tumor Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Gene Therapies for Tumor Treatment Revenue Market Share by Company (2016-2021)
Table 102. India Gene Therapies for Tumor Treatment Sales by Type (2016-2021) & (K Units)
Table 103. India Gene Therapies for Tumor Treatment Sales Market Share by Type (2016-2021)
Table 104. India Gene Therapies for Tumor Treatment Sales by Type (2022-2027) & (K Units)
Table 105. India Gene Therapies for Tumor Treatment Sales Market Share by Type (2022-2027)
Table 106. India Gene Therapies for Tumor Treatment Sales by Application (2016-2021) & (K Units)
Table 107. India Gene Therapies for Tumor Treatment Sales Market Share by Application (2016-2021)
Table 108. India Gene Therapies for Tumor Treatment Sales by Application (2022-2027) & (K Units)
Table 109. India Gene Therapies for Tumor Treatment Sales Market Share by Application (2022-2027)
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Gene Therapies for Tumor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Novartis Gene Therapies for Tumor Treatment Product
Table 114. Novartis Recent Development
Table 115. Kite Pharma Corporation Information
Table 116. Kite Pharma Description and Business Overview
Table 117. Kite Pharma Gene Therapies for Tumor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Kite Pharma Gene Therapies for Tumor Treatment Product
Table 119. Kite Pharma Recent Development
Table 120. Amgen Corporation Information
Table 121. Amgen Description and Business Overview
Table 122. Amgen Gene Therapies for Tumor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Amgen Gene Therapies for Tumor Treatment Product
Table 124. Amgen Recent Development
Table 125. Shanghai Sunway Corporation Information
Table 126. Shanghai Sunway Description and Business Overview
Table 127. Shanghai Sunway Gene Therapies for Tumor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Shanghai Sunway Gene Therapies for Tumor Treatment Product
Table 129. Shanghai Sunway Recent Development
Table 130. Sibiono Corporation Information
Table 131. Sibiono Description and Business Overview
Table 132. Sibiono Gene Therapies for Tumor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Sibiono Gene Therapies for Tumor Treatment Product
Table 134. Sibiono Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Gene Therapies for Tumor Treatment Distributors List
Table 138. Gene Therapies for Tumor Treatment Customers List
Table 139. Gene Therapies for Tumor Treatment Market Trends
Table 140. Gene Therapies for Tumor Treatment Market Drivers
Table 141. Gene Therapies for Tumor Treatment Market Challenges
Table 142. Gene Therapies for Tumor Treatment Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Therapies for Tumor Treatment Product Picture
Figure 2. Global Gene Therapies for Tumor Treatment Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Gene Therapies for Tumor Treatment Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Other Examples
Figure 9. Global Gene Therapies for Tumor Treatment Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Gene Therapies for Tumor Treatment Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Gene Therapies for Tumor Treatment Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Gene Therapies for Tumor Treatment Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Gene Therapies for Tumor Treatment Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Gene Therapies for Tumor Treatment Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Gene Therapies for Tumor Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Gene Therapies for Tumor Treatment Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Gene Therapies for Tumor Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Gene Therapies for Tumor Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Gene Therapies for Tumor Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Gene Therapies for Tumor Treatment Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Gene Therapies for Tumor Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Gene Therapies for Tumor Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Gene Therapies for Tumor Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Gene Therapies for Tumor Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Gene Therapies for Tumor Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Gene Therapies for Tumor Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Gene Therapies for Tumor Treatment Players Market Share by Revenue in Gene Therapies for Tumor Treatment: 2016 & 2020
Figure 28. Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Gene Therapies for Tumor Treatment Revenue Share by Type (2016-2021)
Figure 30. Global Gene Therapies for Tumor Treatment Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Gene Therapies for Tumor Treatment Revenue Share by Application (2016-2021)
Figure 32. Global Gene Therapies for Tumor Treatment Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Gene Therapies for Tumor Treatment Sales Market Share by Type in 2020
Figure 34. North America Gene Therapies for Tumor Treatment Sales Market Share by Application in 2020
Figure 35. Europe Gene Therapies for Tumor Treatment Sales Market Share by Type in 2020
Figure 36. Europe Gene Therapies for Tumor Treatment Sales Market Share by Application in 2020
Figure 37. China Gene Therapies for Tumor Treatment Sales Market Share by Type in 2020
Figure 38. China Gene Therapies for Tumor Treatment Sales Market Share by Application in 2020
Figure 39. Japan Gene Therapies for Tumor Treatment Sales Market Share by Type in 2020
Figure 40. Japan Gene Therapies for Tumor Treatment Sales Market Share by Application in 2020
Figure 41. Southeast Asia Gene Therapies for Tumor Treatment Sales Market Share by Type in 2020
Figure 42. Southeast Asia Gene Therapies for Tumor Treatment Sales Market Share by Application in 2020
Figure 43. India Gene Therapies for Tumor Treatment Sales Market Share by Type in 2020
Figure 44. India Gene Therapies for Tumor Treatment Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Gene Therapies for Tumor Treatment
Figure 47. Manufacturing Process Analysis of Gene Therapies for Tumor Treatment
Figure 48. Gene Therapies for Tumor Treatment Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed